From professional translators, enterprises, web pages and freely available translation repositories.
ho in this leaflet:
i denna bipacksedel finner du information om:
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
ho in patients with a confirmed (i. e. at least two consecutive tests, 3 to 4 weeks apart) fev1 decline of > 20% from baseline, exubera therapy should be discontinued and the patient monitored as
20 fev1 på > 20% från utgångsvärdet bör behandling med exubera avbrytas och patienten kontrolleras efter behov.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
